ACRO Forum ‣ ACRO

About the ACRO Forum

The ACRO Forum was established in 2015 as a special mechanism to interact with TransCelerate BioPharma, Inc. The Forum provides an opportunity for subject matter experts (SMEs) from ACRO members to engage colleagues, provide industry input to TransCelerate workstreams and report back on TransCelerate developments, helping to inform member company perspectives and strategies.

Alan Metz of IQVIA and Sandy Kennedy of Fortrea are the co-Chairs of the ACRO Forum.

Current active initiatives

ICH E6(R3) with a focus on Risk Management
ICH E6(R3) with a focus on Data Governance

Previously, the Forum has worked on a variety of projects with TransCelerate, including Quality Management Systems, eConsent, Site Qualification and Training, Common Protocol Template, eSource and a variety of other workstreams. The Forum’s engagement with a given TransCelerate initiative does not constitute an endorsement of any specific project, vendor, process or technology.

ACRO & TransCelerate Collaborations

Risk Management – Key Changes in Good Clinical Practice ICH E6(R3)

Co-developed by subject matter experts from ACRO and TransCelerate BioPharma, the infographic “Risk Management – Key Changes in Good Clinical Practice ICH E6(R3)” details key changes in Good Clinical Practice ICH E6 between Revisions 2 and 3, summarizing the impact of these changes on risk management practices.